Cholesterol embolization after treatment with tissue plasminogen activator

N Engl J Med. 1989 Nov 2;321(18):1270. doi: 10.1056/NEJM198911023211816.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Cholesterol / blood*
  • Embolism / etiology*
  • Humans
  • Male
  • Middle Aged
  • Recombinant Proteins / adverse effects
  • Tissue Plasminogen Activator / adverse effects*

Substances

  • Recombinant Proteins
  • Cholesterol
  • Tissue Plasminogen Activator